4//SEC Filing
Weisman Harlan F 4
Accession 0001181431-13-003277
CIK 0001429260other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 6:11 PM ET
Size
10.8 KB
Accession
0001181431-13-003277
Insider Transaction Report
Form 4
Weisman Harlan F
DirectorChairman and CEO
Transactions
- Purchase
Common Stock
2013-01-14$5.71/sh+20,000$114,200→ 20,000 total
Holdings
- 25,000
Options to purchase Common Stock
Exercise: $5.72Exp: 2022-08-16→ Common Stock (25,000 underlying) - 1,686,590
Options to purchase Common Stock
Exercise: $5.57Exp: 2023-01-07→ Common Stock (1,686,590 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.63 to $5.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]One-third of the shares will vest on each of August 16, 2013, 2014 and 2015.
- [F3]One-third of the shares will vest on each of December 28, 2013, 2014 and 2015, subject to Dr. Weisman's continued employment with the Issuer.
Issuer
CORONADO BIOSCIENCES INC
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001555563
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 6:11 PM ET
- Size
- 10.8 KB